Mission
Biosonda is a Biotechnology Company focused on researching, developing, producing, and commercializing mollusk hemocyanins. These large glycoproteins act as carriers for generating polyclonal and monoclonal antibodies against haptens and peptides. They are also used as carriers in veterinary vaccines and as adjuvants in some therapeutic cancer vaccines.
Vision
Carrier proteins play an essential role for haptens and peptides, which are small molecules that are antigenic, meaning they are recognized by immune cells, but not immunogenic, as they cannot independently elicit an immune response. When haptens bind to a carrier protein, they become detectable by the immune system, allowing the production of specific antibodies against the hapten.
Consequently, the production of polyclonal and monoclonal antibodies requires efficient carrier systems to generate high-specificity antibodies against small molecules, including drugs, hormones, and peptides, for research and diagnostic purposes.
Furthermore, the effectiveness of immunization protocols is determined not only by the immunogenicity of the antigenic preparation but also by the characteristics of adjuvants. These compounds, which possess diverse chemical nature and properties, are essential for enhancing both innate and adaptive immune responses to antigens.
Adjuvants enhance the efficacy of prophylactic and therapeutic vaccines in both human and veterinary applications, resulting in durable protection against pathogens and tumor cells.
